Pim Berger

Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands.

Part of Schuberg Philis Group BV, Schuberg Philis BV is a Dutch company that believes in the importance of happy colleagues to create happy customers. The company is based in Schiphol-Rijk, Netherlands. The company is convinced that by allowing talented professionals to discover their true strengths, they will become happier and more fulfilled in the process. The CEOs are Arjan Eriks, Tom den Hartog. The company was founded in 2000 by Pim Berger, Gerwin Schuring, Philip Dries.